Back
Sarepta Therapeutics Vs. Dave Industry Stock Comparison
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$16.42
Seasonality Move:
8.09%
Buy
87
DAVE
Dave
Last Price:
$235.68
Seasonality Move:
-15.09%
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $16.75. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $16.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.31 | Buy |
Relative Strength Index (14 RSI): | 44.29 | Sell |
Chaikin Money Flow: | -38189309 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 19.24) | Sell |
Bollinger Bands (100): | (19.96 - 68.68) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 32.73 | Buy |
Relative Strength Index (14 RSI): | 58.07 | Buy |
Chaikin Money Flow: | 366332 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (201.84 - 257.42) | Buy |
Bollinger Bands (100): | (93.8 - 226.28) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.94 | Buy |
20-day SMA: | 16.64 | Buy |
50-day SMA: | 25.51 | Sell |
200-day SMA: | 81.71 | Sell |
8-day EMA: | 6.46 | Buy |
20-day EMA: | 2.96 | Buy |
50-day EMA: | 1.25 | Buy |
200-day EMA: | 0.32 | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 211.5 | Buy |
20-day SMA: | 224.65 | Buy |
50-day SMA: | 220.13 | Buy |
200-day SMA: | 120.71 | Buy |
8-day EMA: | 91.44 | Buy |
20-day EMA: | 41.85 | Buy |
50-day EMA: | 17.72 | Buy |
200-day EMA: | 4.56 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, an increase next quarter of $0.87 per share, a decrease this year of $6.22 per share, and an increase next year of $5.50 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.38 per share, an increase next quarter of $0.54 per share, an increase this year of $4.52 per share, and an increase next year of $1.53 per share.
Sarepta Therapeutics Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |